Spots Global Cancer Trial Database for neuromyelitis optica
Every month we try and update this database with for neuromyelitis optica cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch) | NCT02166346 | Transverse Myel... Neuromyelitis O... Idiopathic Tran... Myelitis NOS | Dalfampridine Placebo | 18 Years - 70 Years | Johns Hopkins University | |
Maintenance Plasma Exchange for Neuromyelitis Optica | NCT01500681 | Neuromyelitis O... Neuromyelitis O... Recurrent Idiop... | Plasma exchange... | 18 Years - | Mayo Clinic | |
A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease) | NCT00304291 | Neuromyelitis O... Myelitis, Trans... Demyelinating A... Autoimmune Dise... | Mitoxantrone | 18 Years - 55 Years | State University of New York at Buffalo | |
Autologous Stem Cell Transplant for Neurologic Autoimmune Diseases | NCT00716066 | Autoimmune Dise... Neurologic Auto... Autologous Tran... Multiple Sclero... MS Stem Cell Tr... Multiple Sclero... Stiff Person Sy... HCT for Neurolo... CIDP Transplant Myasthenia Grav... Autoimmune Nerv... Central Nervous... Cerebellar Dege... Chronic Inflamm... Lambert Eaton M... Myasthenia Grav... Neuromyelitis O... Opsoclonus Myoc... Rasmussen Subac... | Anti-Thymocyte ... Autologous Hema... Carmustine Cytarabine Etoposide Laboratory Biom... Melphalan Peripheral Bloo... Prednisone Syngeneic Bone ... | - 71 Years | Fred Hutchinson Cancer Center | |
A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin Versus Standard Therapy for Transverse Myelitis | NCT02398994 | Myelitis, Trans... Neuromyelitis O... | Intravenous Met... Intravenous Imm... | 1 Year - | Guy's and St Thomas' NHS Foundation Trust | |
Biobank For MS And Other Demyelinating Diseases | NCT00445367 | Multiple Sclero... Transverse Myel... Neuromyelitis O... Acute Dissemina... Optic Neuritis | - | Accelerated Cure Project for Multiple Sclerosis | ||
Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch) | NCT02166346 | Transverse Myel... Neuromyelitis O... Idiopathic Tran... Myelitis NOS | Dalfampridine Placebo | 18 Years - 70 Years | Johns Hopkins University | |
A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin Versus Standard Therapy for Transverse Myelitis | NCT02398994 | Myelitis, Trans... Neuromyelitis O... | Intravenous Met... Intravenous Imm... | 1 Year - | Guy's and St Thomas' NHS Foundation Trust | |
Maintenance Plasma Exchange for Neuromyelitis Optica | NCT01500681 | Neuromyelitis O... Neuromyelitis O... Recurrent Idiop... | Plasma exchange... | 18 Years - | Mayo Clinic | |
Biobank For MS And Other Demyelinating Diseases | NCT00445367 | Multiple Sclero... Transverse Myel... Neuromyelitis O... Acute Dissemina... Optic Neuritis | - | Accelerated Cure Project for Multiple Sclerosis | ||
Biobank For MS And Other Demyelinating Diseases | NCT00445367 | Multiple Sclero... Transverse Myel... Neuromyelitis O... Acute Dissemina... Optic Neuritis | - | Accelerated Cure Project for Multiple Sclerosis | ||
The Longitudinal CONQUER Study of Rare Neuroimmunologic Disorders | NCT01623076 | Neuromyelitis O... Neuromyelitis O... Transverse Myel... Optic Neuritis | 6 Years - | University of Texas Southwestern Medical Center | ||
Safety and Efficacy of Sustained Release Dalfampridine in Transverse Myelitis (Re-Launch) | NCT02166346 | Transverse Myel... Neuromyelitis O... Idiopathic Tran... Myelitis NOS | Dalfampridine Placebo | 18 Years - 70 Years | Johns Hopkins University |